+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Opposite modulation of noradrenaline and ATP release in guinea-pig vas deferens through prejunctional beta-adrenoceptors: evidence for the beta 2 subtype



Opposite modulation of noradrenaline and ATP release in guinea-pig vas deferens through prejunctional beta-adrenoceptors: evidence for the beta 2 subtype



Naunyn-Schmiedeberg's Archives of Pharmacology 353(5): 564-571



Activation of prejunctional beta-adrenoceptors has been suggested to increase the release of noradrenaline but to decrease the neural release of ATP in the guinea-pig vas deferens. Experiments were carried out to determine the subtype of beta-adrenoceptor involved. In [3H]-noradrenaline-preincubated tissues superfused with medium containing prazosin and suramin, isoprenaline (1-100 nM), salbutamol (0.01-1 microM) and terbutaline (0.1-10 microM) increased the overflow of tritium but reduced the overflow of ATP elicited by electrical stimulation (210 pulses/7 Hz). The effects of isoprenaline were blocked by the beta 2-selective antagonist 1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3- [(1-methylethyl)amino]-2-butanol (ICI 118,551; 100 nM). In prazosin- and suramin-free medium, isoprenaline (100 nM) did not change the overflow of ATP elicited by exogenous noradrenaline (10 microM). Isoprenaline (1-100 nM), salbutamol (0.01-1 microM) and terbutaline (0.1-10 microM) reduced the initial twitch contraction elicited by electrical stimulation (210 pulses/7 Hz) in prazosin- and suramin-free medium as well as the isolated purinergic neurogenic contraction obtained by exposure to prazosin. They increased or tended to increase the secondary sustained concentration elicited by electrical stimulation in prazosin- and suramin-free medium as well as the isolated adrenergic neurogenic contraction obtained in the presence of suramin. The inhibition by isoprenaline of the isolated purinergic contraction was attenuated by ICI 118,551 (100 nM) but not by the beta 1-selective antagonist 1-[2-((3-carbamoyl- 4-hydroxy)phenoxy)ethylamino]-3-[4-(1-methyl-4- trifluoromethyl-2-imidazolyl)phenoxy]-2-propanol (CGP 20712A; 100 nM). The results confirm the opposite beta-adrenoceptor-mediated modulation of noradrenaline and neural ATP release in the guinea-pig vas deferens. They show that the prejunctional beta-adrenoceptor is of the beta 2-subtype.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046870461

Download citation: RISBibTeXText

PMID: 8740151


Related references

Opposite modulation of noradrenaline and ATP release in guinea-pig vas deferens through prejunctional beta-adrenoceptors. Naunyn-Schmiedeberg's Archives of Pharmacology 353(4 Suppl. ): R85, 1996

Opposite modulation of cotransmitter release in guinea-pig vas deferens: increase of noradrenaline and decrease of ATP release by activation of prejunctional beta-adrenoceptors. Naunyn-Schmiedeberg's Archives of Pharmacology 353(2): 184-192, 1996

Prejunctional 1-adrenoceptors modify release of [3H]noradrenaline in the guinea-pig vas deferens. General Pharmacology: The Vascular System 21(1): 53-57, 1990

Prejunctional alpha 1-adrenoceptors modify release of [3H]noradrenaline in the guinea-pig vas deferens. General Pharmacology 21(1): 53-57, 1990

Prejunctional alpha 1 adrenoceptors modify release of tritiated noradrenaline in the guinea pig vas deferens. General Pharmacology 21(1): 53-58, 1990

The role of angiotensin ii in the facilitation of noradrenaline release by prejunctional beta 2 adrenoceptors in the vasculature of the freely moving rat. European Journal of Pharmacology 183(5): 2039, 1990

Facilitation of noradrenaline release from sympathetic nerves in rat anococcygeus muscle by activation of prejunctional beta-adrenoceptors and angiotensin receptors. British Journal of Pharmacology 95(2): 385-392, 1988

Dopa decarboxylase assay provides evidence that l dopa itself facilitates release of noradrenaline via presynaptic beta 1 adrenoceptors and beta 2 adrenoceptors in rat hypothalamic slices. European Journal of Pharmacology 183(2): 416-417, 1990

Noradrenaline release evoked by a physiological irregular sympathetic discharge pattern is modulated by prejunctional alpha- and beta-adrenoceptors in vivo. British Journal of Pharmacology 95(4): 1101-1108, 1988

Prejunctional Modulation of Noradrenaline Release by α2-Adrenoceptors. Journal of Cardiovascular Pharmacology 4: S35-S40, 1982

Prejunctional modulation of noradrenaline release in mouse and rat vas deferens: Contribution of P-1- and P-2-purinoceptors. British Journal of Pharmacology 110(4): 1465-1472, 1993

Modulation of noradrenaline release in vivo through prejunctional alpha-adrenoceptors. Clinical and Experimental Pharmacology and Physiology 14(5): 449-454, 1987

Beta 2- but not beta 3-adrenoceptors mediate prejunctional inhibition of non-adrenergic non-cholinergic contraction of guinea pig main bronchi. European Journal of Pharmacology 275(2): 199-206, 1995

The modulation of head-twitch behaviour by drugs acting on beta-adrenoceptors: evidence for the involvement of both beta 1- and beta 2-adrenoceptors. Psychopharmacology 88(3): 320-324, 1986

Modulation of noradrenaline release in vivo through facilitatory beta 2 adrenoceptors. Naunyn-Schmiedeberg's Archives of Pharmacology 324(Suppl.): R15, 1983